Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Alexander Kudryavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
(2022)
Open Access | Times Cited: 10

Showing 10 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients
Patrick Affeldt, Felix C. Koehler, Karl August Brensing, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2646-2646
Open Access | Times Cited: 22
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Nickolay A. Kryuchkov, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 326-326
Open Access | Times Cited: 10
(+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
Aleksandr S. Filimonov, Оlga I. Yarovaya, Anna V. Zaykovskaya, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2154-2154
Open Access | Times Cited: 11
Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants
Ji Woong Kim, Ah Hyun Cho, Ha Gyeong Shin, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 174-174
Open Access | Times Cited: 6
Emergence of Genomic Diversity in the Spike Protein of the “Omicron” Variant
Surajit Basak, Pratanu Kayet, Manisha Ghosh, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2132-2132
Open Access | Times Cited: 5
Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2
Atharv Athavale, A Gaur, Nafees Ahmed, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1396-1396
Open Access
Page 1

Scroll to top